[Evaluation of methodological and reporting quality of domestic clinical guidelines for hyperuricemia].

This study aims to evaluate the methodological and reporting quality of diagnosis and treatment guidelines for hyperuricemia as well as the expert consensuses and promote the understanding and application of the diagnosis and treatment guidelines for hyperuricemia. With "hyperuricemia" "guidelines" "consensus" "recommendations" as the key words in titles, the authors searched for the published clinical guidelines on hyperuricemia in Chinese against CNKI, Wanfang, VIP, Medlive and the official website of the industry association. The retrieval time limit was until May 31, 2021. The appraisal of guidelines for research and evaluation Ⅱ(AGREEⅡ) and the reporting items for practice guidelines in health care(RIGHT) were employed to evaluate the methodological quality and reporting quality of 14 guidelines/consensuses included. The average scores of the guidelines/consensuses were 80.85%(48.61%-98.61%) for the domain of scope and purpose, 34.52%(0-69.44%) for the domain of stakeholder involvement, 35.53%(6.25%-92.19%) for the domain of rigor of development, 55.85%(23.61%-86.11%) for the domain of clarity of presentation, 26.19%(0-76.04%) for the domain of applicability, and 21.42%(0-50.00%) for the domain of editorial independence. Nine guidelines/consensuses were of medium overall quality with grade B recommendation, and five guidelines/consensuses were of poor quality with grade C recommendation. The RIGHT classified the fourteen guidelines/consensuses into one of high reporting quality, three of medium reporting quality, and ten of low reporting quality. The results of this study indicate that the standardization and rigor of the methodological quality and the reporting quality of the clinical guidelines/consensuses for hyperuricemia in China remain to be strengthened.

Nanosized metal oxide and nanobelts prepared by selective dealloying of Ti-based amorphous powders.

Two typical nanomaterials, nanosized metal oxides and nanobelts, are obtained in one-pot selective dealloying process by using multiple-component Ti-based amorphous powders as dealloying precursors. The microstructure and photoelectric conversion property of the as-synthesized Zr-doped nanobelts are comprehensively investigated. Particularly, a core-shell structure, for example, residual amorphous alloy as the microsized core and nanosized metal oxide composites (mainly TiO2 and CuO) as the shell, forms as a byproduct of the selective dealloying. These resultant metal oxide composites show large specific surface area, and superior adsorption efficiency and capacity for removing toxic Cr(6+) in aqueous solution. The differences in the standard electrode potentials between the multiple-component elements in amorphous powders trigger their selective dealloying in alkaline solutions.

[The intercostal nerve transplantation with olfactory ensheathing cells modified by NGF, BDNF genes repairs the injured rat spinal cord].

OBJECTIVE: To study the repairable effects of intercostal nerve transplantation with NGF,BDNF genes modifying olfactory Ensheathing cells (OECs) on spinal cord injury (SCI). METHODS: The spinal cord hemisection model was made by cutting 2 mm rat spinal cord from T11 and T12. And then the lesion was repaired using intercostal nerve linking manner (proximal gray substance to distal white substance and L1, L2, L3, L4 of radix posterior and proximal white substance), and with NGF, BDNF genes modifying OECs were transplanted into group A. However, the group B was only transplanted to get the intercostal nerve but no OECs, the group C was without treatment but an absorbable gelatin sponge was used to SCI. The operated model rat had been bred for 4 to 8 weeks. The BBB scores were checked, and the somatosensory evoked potentials (SEP), motor evoked potentials (MEP) were examined, and the tissue structure of the operated region was observed under the light microscope. RESULTS: The 8 weeks of after operation, the back limbs function of group A rats was recovered, and BBB scores were A>B>C, and the peak latencies of early waves in SEP and MEP were A

Preparation and investigation of CaZr4(PO4)6:Dy(3+) single-phase full-color phosphor.

A novel single-phase full-color phosphor CaZr4(PO4)6:Dy(3+) has been synthesized by a high-temperature solid-state reaction. X-ray powder diffraction (XRD) analysis and FT-IR spectra confirmed the phase formation of CaZr4(PO4)6:Dy(3+) materials. The photoluminescence excitation and emission spectra, the concentration dependence of the emission intensity, decay curves, ultraviolet-visible absorption spectroscopy and Commission International de I(')Eclairage (CIE) of the phosphor were investigated. The results showed that the phosphor could be efficiently excited by the near ultraviolet (NUV) light region from 340 to 440 nm, and it exhibited blue (487 nm) and yellow (577 nm) emission corresponding to (4)F9/2→(6)H15/2 transitions and (4)F9/2→(6)H13/2 transitions, respectively. The luminescence intensity of Ca(1-x)Zr4(PO4)6:xDy(3+) phosphor firstly increased and then decreased with increasing Dy(3+) concentration, and reached the maximum at x=0.04. The band gap energy of CaZr4(PO4)6 and Ca0.96Zr4(PO4)6:0.04Dy(3+) are about 4.184 eV from the diffuse reflection spectrum. The decay time was also determined for various concentrations of Dy(3+) in CaZr4(PO4)6. The calculated color coordinates lies in the blue white region. Therefore, these obtained results suggest that the prepared phosphors exhibit great potential for use as single-phase full-color phosphor for near ultraviolet white light emitting diodes (NUV WLEDs).

Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression.

AIM: To investigate the effects of dihydromyricetin (DHM) on the migration and invasion of human hepatic cancer cells. METHODS: The hepatoma cell lines SK-Hep-1 and MHCC97L were used in this study. The cells were cultured in RPIM-1640 medium supplemented with 10% fetal bovine serum at 37 °C in a humidified 5% CO2 incubator. DHM was dissolved in dimethyl sulfoxide and diluted to various concentrations in medium before applying to cells. MTT assays were performed to measure the viability of the cells after DHM treatment. Wound healing and Boyden transwell assays were used to assess cancer cell motility. The invasive capacity of cancer cells was measured using Matrigel-coated transwell chambers. Matrix metalloproteinase (MMP)-2/9 activity was examined by fluorescence analysis. Western blot was carried out to analyze the expression of MMP-2, MMP-9, p-38, JNK, ERK1/2 and PKC-δ proteins. All data were analyzed by Student's t tests in GraphPad prism 5.0 software and are presented as mean ± SD. RESULTS: DHM was found to strongly inhibit the migration of the hepatoma cell lines SK-Hep-1 (without DHM, 24 h: 120 ± 8 µmol/L vs 100 µmol/L DHM, 24 h: 65 ± 10 µmol/L, P < 0.001) and MHCC97L (without DHM, 24 h: 126 ± 7 µmol/L vs 100 µmol/L DHM, 24 h: 74 ± 6 µmol/L, P < 0.001). The invasive capacity of the cells was reduced by DHM treatment (SK-Hep-1 cells without DHM, 24 h: 67 ± 4 µmol/L vs 100 µmol/L DHM, 24 h: 9 ± 3 µmol/L, P < 0.001; MHCC97L cells without DHM, 24 h: 117 ± 8 µmol/L vs 100 µmol/L DHM, 24 h: 45 ± 2 µmol/L, P < 0.001). MMP2/9 activity was also inhibited by DHM exposure (SK-Hep-1 cells without DHM, 24 h: 600 ± 26 µmol/L vs 100 µmol/L DHM, 24 h: 100 ± 6 µmol/L, P < 0.001; MHCC97L cells without DHM, 24 h: 504 ± 32 µmol/L vs 100 µmol/L DHM 24 h: 156 ± 10 µmol/L, P < 0.001). Western blot analysis showed that DHM decreased the expression level of MMP-9 but had little effect on MMP-2. Further investigation indicated that DHM markedly reduced the phosphorylation levels of p38, ERK1/2 and JNK in a concentration-dependent manner but had no impact on the total protein levels. In addition, PKC-δ protein, a key protein in the regulation of MMP family protein expression, was up-regulated with DHM treatment. CONCLUSION: These findings demonstrate that DHM inhibits the migration and invasion of hepatoma cells and may serve as a potential candidate agent for the prevention of HCC metastasis.

Neuropeptide Y Gene Promoter -399T/C Polymorphism Increases Risk of Ischemic Stroke.

BACKGROUND: Several genetic factors underlying ischemic stroke have been identified. Variants of Neuropeptide Y (NPY), whose product plays diverse roles in modulating physiological functions, have been associated with an increased risk of ischemic stroke in South Korean individuals. AIMS: We explored the association between a polymorphism in the NPY gene promoter at position -399 and the risk of ischemic stroke in Han Chinese. STUDY DESIGN: Case-control study. METHODS: The polymorphism -399T/C in the promoter of NPY was analysed in 500 patients with ischemic stroke and 500 healthy individuals by amplification and sequencing of this region. Non-conditional logistic regression was used to analyse association between genotypes and the risk of ischemic stroke. RESULTS: Genotype and allele frequencies differed significantly between the ischemic stroke and control groups (P<0.05). Additionally, compared to stroke patients with the TT genotype, those with the CC genotype had a 1.7-times higher risk of ischemic stroke (OR=1.739, 95%CI=1.201-2.520, P=0.003), especially for those who were over 60 years old or male. Individuals with the TC genotype did not have an increased risk of ischemic stroke (P>0.05). CONCLUSION: The -399T/C polymorphism of the NPY gene is associated with ischemic stroke in Han Chinese individuals, and the CC genotype may be a risk factor for ischemic stroke.